Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Clariane SE (CLARI.PA)
EUR4.05
+0.01 (+0.35%)
FR PAR Healthcare Medical - Care Facilities
Address
21 - 25 rue Balzac 75008
Paris, IF, FR
Paris, IF, FR
CEO
Sophie Boissard
Website
clariane.com
IPO
2023-06-12
ISIN FR0010386334
Also trades on
Euronext Paris · CLARI.PA (EUR)
Euronext Paris · KORI.PA (EUR)
London Stock Exchange · 0OPS.L (EUR)
Description
Clariane SE, established in Paris, France, in 2001 and known as Korian until its rebranding in June 2023, specializes in delivering comprehensive medical and non-medical care and support. The company serves senior citizens and individuals facing either temporary or chronic health challenges through a diverse range of provisions. These offerings encompass residential facilities like long-term nursing homes, specialized medical clinics, and senior living communities, including assisted living and co-housing arrangements. Furthermore, Clariane extends its services to include in-home care, various support programs, and hospitalization. Its operational footprint spans multiple European nations, including France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR4.05
+0.01 (+0.35%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
343.8K
Beta
0.82
Float Shares
303.31M
Free Float %
85.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.71% | +1.11% | +3.61% | +2.85% | +12.23% | +6.51% | +10.74% | -9.39% | -77.65% | -75.22% | -80.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
4.05
DCF (Unlevered)
25.63
+532.5%
DCF (Levered)
17.95
+343.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
43% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 3 | +1 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
0.75
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+0.5% Q4'25: +3.6% (vs Q4'23)
-
EPS growth Medical - Care Facilities: +19.2%+102.7% ★ Q4'25: +127.0% (vs Q4'23)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+11.4% ★ Q4'25: +15.4% (vs Q4'23)
-
EBIT margin Medical - Care Facilities: +11.3%+5.6% Q4'25: -4.3% (vs Q4'23)
-
ROIC Medical - Care Facilities: +6.8%+2.1% Q4'25: -2.6% (vs Q4'23)
-
Share dilution Medical - Care Facilities: +0.0%+53.7% Q4'25: +144.5% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×11.22× Q4'25: 11.66× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 2 EPS Ana. |
Dec 2027 5 Rev. Ana. 2 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.57B
est: 2.58B (-0.2%)
|
2.98B
est: 2.99B (-0.2%)
|
3.13B
est: 3.13B (0.0%)
|
3.34B
est: 3.34B (+0.0%)
|
3.61B
est: 3.61B (+0.1%)
|
3.77B
est: 3.82B (-1.2%)
|
4.14B
est: 4.29B (-3.6%)
|
4.44B
est: 4.59B (-3.2%)
|
5.00B
est: 5.17B (-3.4%)
|
5.28B
est: 5.27B (+0.1%)
|
5.31B
est: 5.36B (-0.8%)
|
5.40B
5.37B – 5.51B
+0.9% YoY
|
5.62B
5.57B – 5.75B
+4.0% YoY
|
5.82B
5.82B – 5.82B
+3.5% YoY
|
6.06B
6.01B – 6.19B
+4.2% YoY
|
6.34B
6.29B – 6.48B
+4.7% YoY
|
| EBITDA |
313.42M
est: 533.45M (-41.2%)
|
386.02M
est: 617.73M (-37.5%)
|
433.83M
est: 647.85M (-33.0%)
|
467.15M
est: 689.95M (-32.3%)
|
884.90M
est: 746.71M (+18.5%)
|
828.99M
est: 789.42M (+5.0%)
|
946.76M
est: 887.25M (+6.7%)
|
907.45M
est: 948.74M (-4.4%)
|
952.04M
est: 1.04B (-8.4%)
|
1.01B
est: 1.06B (-5.1%)
|
1.01B
est: 1.08B (-6.0%)
|
1.09B
1.08B – 1.11B
+0.9% YoY
|
1.13B
1.12B – 1.16B
+4.0% YoY
|
1.17B
1.17B – 1.17B
+3.5% YoY
|
1.22B
1.21B – 1.24B
+4.2% YoY
|
1.27B
1.26B – 1.30B
+4.7% YoY
|
| EBIT |
167.28M
est: 163.86M (+2.1%)
|
206.15M
est: 189.75M (+8.6%)
|
280.17M
est: 199.00M (+40.8%)
|
277.70M
est: 211.94M (+31.0%)
|
339.58M
est: 229.37M (+48.1%)
|
272.31M
est: 242.49M (+12.3%)
|
331.00M
est: 272.54M (+21.4%)
|
253.84M
est: 291.43M (-12.9%)
|
263.52M
est: 311.65M (-15.4%)
|
299.70M
est: 317.92M (-5.7%)
|
297.00M
est: 322.84M (-8.0%)
|
325.78M
323.52M – 332.27M
+0.9% YoY
|
338.98M
335.52M – 346.50M
+4.0% YoY
|
350.71M
350.71M – 350.71M
+3.5% YoY
|
365.31M
362.16M – 373.01M
+4.2% YoY
|
382.39M
379.10M – 390.45M
+4.7% YoY
|
| Net Income |
58.69M
est: 172.00M (-65.9%)
|
131.29M
est: 146.77M (-10.5%)
|
163.32M
est: 157.79M (+3.5%)
|
123.13M
est: 179.43M (-31.4%)
|
114.68M
est: 222.44M (-48.4%)
|
39.40M
est: 102.59M (-61.6%)
|
91.12M
est: 163.89M (-44.4%)
|
22.06M
est: 128.60M (-82.8%)
|
-105.25M
est: -17.04B (+99.4%)
|
-55.12M
est: -18.37M (-200.0%)
|
1.60M
est: 56.09M (-97.1%)
|
146.11M
143.31M – 148.91M
+160.5% YoY
|
142.75M
81.36M – 321.94M
-2.3% YoY
|
88.95M
15.42M – 242.93M
-37.7% YoY
|
204.02M
201.74M – 209.61M
+129.4% YoY
|
270.22M
267.20M – 277.63M
+32.5% YoY
|
| SGA |
664.27M
est: 222.80M (+198.1%)
|
727.77M
est: 258.00M (+182.1%)
|
734.54M
est: 270.58M (+171.5%)
|
765.43M
est: 288.16M (+165.6%)
|
448.90M
est: 311.87M (+43.9%)
|
437.01M
est: 329.70M (+32.5%)
|
429.85M
est: 370.57M (+16.0%)
|
457.83M
est: 396.25M (+15.5%)
|
544.63M
est: 341.87M (+59.3%)
|
—
est: 348.75M (-100.0%)
|
77.30M
est: 354.14M (-78.2%)
|
357.37M
354.89M – 364.49M
+0.9% YoY
|
371.84M
368.05M – 380.10M
+4.0% YoY
|
384.71M
384.71M – 384.72M
+3.5% YoY
|
400.72M
397.28M – 409.17M
+4.2% YoY
|
419.47M
415.86M – 428.31M
+4.7% YoY
|
| EPS |
0.68
est: 0.74 (-8.5%)
|
1.51
est: 0.63 (+138.1%)
|
1.85
est: 0.68 (+171.3%)
|
1.28
est: 0.78 (+65.1%)
|
1.29
est: 0.96 (+34.2%)
|
0.43
est: 0.44 (-3.0%)
|
0.95
est: 0.71 (+34.1%)
|
0.21
est: 0.56 (-62.2%)
|
-0.87
est: -47.54 (+98.2%)
|
-0.17
est: -0.05 (-231.6%)
|
0.00
est: 0.16 (-97.1%)
|
0.41
0.40 – 0.42
+158.4% YoY
|
0.61
0.23 – 0.91
+49.2% YoY
|
0.39
0.04 – 0.68
-35.8% YoY
|
0.57
0.57 – 0.59
+47.0% YoY
|
0.76
0.75 – 0.78
+32.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-27 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-26 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-25 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-19 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-18 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-15 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-14 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-13 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
2.43B
OE per share TTM
11.47
Owner's Yield
162.97%
Maintenance CapEx ratio
20.58%
Maint CapEx / Avg PPE
143.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 67 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Global X - Aging Population ETF AGNG | 0.31% | 263.3K | 0.50% |
| 2 | Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF Dist MMS.PA | 0.15% | 1.03M | 0.40% |
| 3 | State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR Acc ZPRX.DE | 0.11% | 826.5K | 0.30% |
| 4 | Schwab Fundamental International Small Company Index ETF FNDC | 0.09% | 2.60M | 0.39% |
| 5 | UBS MSCI EMU Small Cap UCITS ETF EUR dis UEFD.DE | 0.08% | 607.7K | 0.33% |
| 6 | iShares MSCI EMU Small Cap UCITS ETF CES1.L | 0.08% | 828.5K | 0.58% |
| 7 | Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Acc CEM.PA | 0.06% | 215.3K | 0.23% |
| 8 | Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Dist X026.DE | 0.06% | 215.3K | 0.23% |
| 9 | Dimensional - International Small Cap Value ETF DISV | 0.06% | 2.83M | 0.42% |
| 10 | iShares Ageing Population UCITS ETF AGED.L | 0.06% | 512.7K | 0.40% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
4.8K
Shares Outstanding
356.50M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sophie Boissard | Chief Executive Officer & Director | 1M | female |
| Charles-Antoine Pinel | Group Chief Revenue & Development Officer | — | male |
| Christian Gharieb | Chief Executive Officer of Korian Germany & Member of the Group's Management Board | — | male |
| Frédéric Durousseau | Chief Executive Officer of Clariane Real Estate | — | male |
| Grégory Lovichi | Group Chief Financial Officer | — | male |
| Nadege Plou | Group Chief Human Resources Officer | — | female |
| Nicolas Pecourt | Group Chief Communications Officer | — | male |
| Rémi Boyer | Deputy Chief Executive Officer & Chair of the Sup. Board of Korian Germany and Chair of the BOD of Korian Belgium | — | male |
| Aymeric Mathias | President of Clariane France & Member of the Group's Management Board | — | male |
| Stephane Bisseuil | Head of Investor Relations | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CLARI.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
